Literature DB >> 21151787

Cadaveric Renal Transplantation With Cyclosporin-A and Steroids.

T R Hakala1, T E Starzl, J T Rosenthal, B Shaw, S Iwatsuki.   

Abstract

Entities:  

Year:  1983        PMID： 21151787      PMCID： PMC3000048     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  10 in total

1.  Biological effects of cyclosporin A: a new antilymphocytic agent.

Authors:  J F Borel; C Feurer; H U Gubler; H Stähelin
Journal:  Agents Actions       Date:  1976-07

2.  Liver transplantation with use of cyclosporin a and prednisone.

Authors:  T E Starzl; G B Klintmalm; K A Porter; S Iwatsuki; G P Schröter
Journal:  N Engl J Med       Date:  1981-07-30       Impact factor: 91.245

3.  Lymphoma in renal allograft patients treated with cyclosporin-A as one of the immunosuppressive agents.

Authors:  S Thiru; R Y Calne; J Nagington
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

4.  Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers.

Authors:  R Y Calne; K Rolles; D J White; S Thiru; D B Evans; P McMaster; D C Dunn; G N Craddock; R G Henderson; S Aziz; P Lewis
Journal:  Lancet       Date:  1979-11-17       Impact factor: 79.321

5.  Variable convalescence and therapy after cadaveric renal transplantation under cyclosporin A and steroids.

Authors:  T E Starzl; T R Hakala; J T Rosenthal; S Iwatsuki; B W Shaw
Journal:  Surg Gynecol Obstet       Date:  1982-06

6.  Cyclosporin A in renal transplantation: a prospective randomized trial.

Authors:  R M Ferguson; J J Rynasiewicz; D E Sutherland; R L Simmons; J S Najarian
Journal:  Surgery       Date:  1982-08       Impact factor: 3.982

7.  Cyclosporin A in patients receiving renal allografts from cadaver donors.

Authors:  R Y Calne; D J White; S Thiru; D B Evans; P McMaster; D C Dunn; G N Craddock; B D Pentlow; K Rolles
Journal:  Lancet       Date:  1978 Dec 23-30       Impact factor: 79.321

8.  Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A.

Authors:  R Y Calne; D J White; K Rolles; D P Smith; B M Herbertson
Journal:  Lancet       Date:  1978-06-03       Impact factor: 79.321

9.  Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment.

Authors:  C J Green; A C Allison
Journal:  Lancet       Date:  1978-06-03       Impact factor: 79.321

10.  The use of cyclosporin A and prednisone in cadaver kidney transplantation.

Authors:  T E Starzl; R Weil; S Iwatsuki; G Klintmalm; G P Schröter; L J Koep; Y Iwaki; P I Terasaki; K A Porter
Journal:  Surg Gynecol Obstet       Date:  1980-07
  10 in total
  6 in total

1.  Histiocytic Lymphoma in Renal Transplant Patients Receiving Cyclosporine.

Authors:  J T Rosenthal; S Iwatsuki; T E Starzl; R J Taylor; T R Hakala
Journal:  Transplant Proc       Date:  1983-12       Impact factor: 1.066

Review 2.  Cyclosporin: a pharmacoeconomic evaluation of its use in renal transplantation.

Authors:  J E Frampton; D Faulds
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

3.  Graft survival and long-term renal function after sequential conventional cyclosporin A therapy in cadaver kidney transplantation--a prospective randomized trial.

Authors:  R Grundmann; U Hesse; P Wienand; C Baldamus; W Arns
Journal:  Klin Wochenschr       Date:  1987-09-15

4.  [Use and limits of preventive antilymphocyte globulin therapy following kidney transplantation. A prospective randomized study].

Authors:  R Grundmann; P Wienand; G Meider; V Vlaho; H Pichlmaier
Journal:  Klin Wochenschr       Date:  1984-10-15

5.  Cadaveric renal transplantation under cyclosporine-steroid therapy.

Authors:  J T Rosenthal; T R Hakala; S Iwatsuki; B W Shaw; T E Starzl
Journal:  Surg Gynecol Obstet       Date:  1983-10

Review 6.  Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management.

Authors:  Nicole A Pilch; Lyndsey J Bowman; David J Taber
Journal:  Pharmacotherapy       Date:  2020-12-30       Impact factor: 4.705
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.